William B. Walkup & Associates’s Zimmer Biomet ZBH Stock Holding History

William B. Walkup & Associates’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$365K	Buy	4,238 +202	+5%	+$17.7K	0.18%	75
2026 Q1	$457K	Sell	4,036 -264	-6%	-$24.2K	0.27%	63
2025 Q4	$387K	Buy	4,300 +226	+6%	+$21.4K	0.21%	70
2025 Q3	$401K	Buy	4,074 +38	+0.9%	+$3.77K	0.21%	70
2025 Q2	$368K	Hold	4,036	–	–	0.22%	71
2025 Q1	$457K	Hold	4,036	–	–	0.28%	62
2024 Q4	$426K	Sell	4,036 -525	-12%	-$56.3K	0.27%	68
2024 Q3	$492K	Hold	4,561	–	–	0.3%	66
2024 Q2	$495K	Buy	+4,561	New	+$538K	0.32%	63

Other funds holding ZBH

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

CapitalatWork SA Auderghem $3.99B AUM

MPMG

Minneapolis Portfolio Management Group Wayzata, Minnesota $1.06B AUM 63.37% 1-Year Est. Return

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

EIP

Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

William B. Walkup & Associates's ZBH Position: Q2 2026 in Review

William B. Walkup & Associates increased its Zimmer Biomet (ZBH) stake by 5% in Q2 2026, buying an estimated $17.7K and bringing the position to 4,238 shares worth $365K. The position accounts for 0.18% of the portfolio, ranked #75.

William B. Walkup & Associates first reported a position in ZBH in Q2 2024 and has held it in 9 quarters since. The position peaked at $495K in Q2 2024. 348 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

William B. Walkup & Associates held 4,238 shares of Zimmer Biomet worth $365K as of Q2 2026.
William B. Walkup & Associates bought 202 Zimmer Biomet shares in Q2 2026, an estimated $17.7K.
Zimmer Biomet made up 0.18% of William B. Walkup & Associates's portfolio in Q2 2026, its #75 holding.
William B. Walkup & Associates first reported a position in Zimmer Biomet in Q2 2024 and has held it in 9 quarters since.
William B. Walkup & Associates's Zimmer Biomet position peaked at $495K in Q2 2024.
348 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on William B. Walkup & Associates's 13F filing for Q2 2026, filed 30 Jul 2026.